We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.17B
AUM Growth
+$137M
Cap. Flow
+$273M
Cap. Flow %
23.33%
Top 10 Hldgs %
50.6%
Holding
152
New
28
Increased
32
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$18.2M
2
CRMT icon
America's Car Mart
CRMT
+$13M
3
PTON icon
Peloton Interactive
PTON
+$12.7M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$11.5M
5
NDLS icon
Noodles & Co
NDLS
+$7.52M

Top Sells

Rank Stock Value
1
TBBK icon
The Bancorp
TBBK
+$14M
2
AUTL
Autolus Therapeutics
AUTL
+$10.2M
3
CASH icon
Pathward Financial
CASH
+$8.42M
4
MAX icon
MediaAlpha
MAX
+$8.11M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$6.53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.11%
2 Consumer Discretionary 9.31%
3 Financials 6.27%
4 Communication Services 5.51%
5 Technology 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
51
Cytokinetics
CYTK
$10.8B
$5.28M 0.45%
179,257
– –
VTYX
52
DELISTED
Ventyx Biosciences
VTYX
$5.13M 0.44%
147,623
-45,048
-23% -$1.56M
KRTX
53
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.07M 0.43%
30,000
– –
GOSS icon
54
Gossamer Bio
GOSS
$86.2M
$5.07M 0.43%
+6,089,471
New +$7.02M
IMAX icon
55
CALL
IMAX
IMAX
$2.83B
$4.83M 0.41%
250,000
– –
DNTH icon
56
Dianthus Therapeutics
DNTH
$6.21B
$4.6M 0.39%
336,862
+24,362
+8% +$307K
GMDA
57
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$4.45M 0.38%
+4,325,000
New +$5.53M
XTNT icon
58
Xtant Medical Holdings
XTNT
$46.3M
$4.4M 0.38%
+4,000,000
New +$4.29M
BXMT icon
59
PUT
Blackstone Mortgage Trust
BXMT
$2.43B
$4.35M 0.37%
200,000
-200,000
-50% -$4.44M
VNDA icon
60
Vanda Pharmaceuticals
VNDA
$298M
$4.32M 0.37%
+1,000,000
New +$5.56M
PTON icon
61
CALL
Peloton Interactive
PTON
$2.45B
$4.3M 0.37%
852,000
+72,000
+9% +$512K
SPRY icon
62
ARS Pharmaceuticals
SPRY
$584M
$4.15M 0.35%
1,099,075
+918,978
+510% +$6.03M
OPTN
63
DELISTED
OptiNose
OPTN
$4.07M 0.35%
220,529
+41,751
+23% +$752K
IDYA icon
64
IDEAYA Biosciences
IDYA
$3.54B
$3.94M 0.34%
145,860
– –
SVRA icon
65
Savara
SVRA
$1.17B
$3.93M 0.34%
+1,039,364
New +$3.71M
ALTG icon
66
Alta Equipment Group
ALTG
$245M
$3.89M 0.33%
322,632
-100,180
-24% -$1.5M
AGS
67
DELISTED
PlayAGS
AGS
$3.88M 0.33%
594,574
+42,061
+8% +$281K
IWM icon
68
iShares Russell 2000 ETF
IWM
$81.7B
$3.87M 0.33%
21,878
-34,794
-61% -$6.53M
EOLS icon
69
Evolus
EOLS
$516M
$3.85M 0.33%
+421,220
New +$3.78M
TELA icon
70
TELA Bio
TELA
$37M
$3.65M 0.31%
456,092
+100,000
+28% +$929K
ASPS icon
71
Altisource Portfolio Solutions
ASPS
$65.1M
$3.61M 0.31%
+113,058
New +$4.26M
SNDX icon
72
Syndax Pharmaceuticals
SNDX
$1.8B
$3.49M 0.3%
240,031
-83,103
-26% -$1.57M
PNT
73
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$3.48M 0.3%
521,191
-51,000
-9% -$424K
INMD icon
74
PUT
InMode
INMD
$874M
$3.05M 0.26%
+100,000
New +$3.93M
UNCY icon
75
Unicycive Therapeutics
UNCY
$138M
$2.98M 0.26%
347,054
+282,312
+436% +$2.64M
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Nantahala Capital Management held 152 positions worth $1.17B, up 13% from $1.03B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Nantahala Capital Management deployed $273M of net new capital in Q3 2023, opening 28 new positions and adding to 32 existing holdings. Its largest new stake was Assertio: 311,333 shares worth $12M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was The Bancorp, an estimated $14M trimmed.

  • Nantahala Capital Management's largest Q3 2023 buy was Assertio: 311,333 shares worth $12M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2023, an estimated $13M increase.
  • Nantahala Capital Management's biggest Q3 2023 reduction was The Bancorp, cutting an estimated $14M.
  • Nantahala Capital Management fully exited Autolus Therapeutics in Q3 2023, selling an estimated $10.2M.
  • Nantahala Capital Management's ten largest holdings make up 51% of its $1.17B portfolio in Q3 2023.
  • Nantahala Capital Management opened 28 new positions and closed 19 in Q3 2023.
  • Nantahala Capital Management's portfolio value rose 13% quarter-over-quarter to $1.17B.

Based on Nantahala Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.